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Abstract
It has been suggested that oxidative stress may play a role in the pathogenesis of Autism Spectrum Disorders (ASD), but the
literature reports somewhat contradictory results. To further investigate the issue, we evaluated a high number of
peripheral oxidative stress parameters, and some related issues such as erythrocyte membrane functional features and lipid
composition. Twenty-one autistic children (Au) aged 5 to 12 years, were gender and age-matched with 20 typically
developing children (TD). Erythrocyte thiobarbituric acid reactive substances, urinary isoprostane and hexanoyl-lysine
adduct levels were elevated in Au, thus confirming the occurrence of an imbalance of the redox status of Au, whilst other
oxidative stress markers or associated parameters (urinary 8-oxo-dG, plasma radical absorbance capacity and carbonyl
groups, erythrocyte superoxide dismutase and catalase activities) were unchanged. A very significant reduction of Na+/K+-
ATPase activity (266%, p,0.0001), a reduction of erythrocyte membrane fluidity and alteration in erythrocyte fatty acid
membrane profile (increase in monounsaturated fatty acids, decrease in EPA and DHA-v3 with a consequent increase in v6/
v3 ratio) were found in Au compared to TD, without change in membrane sialic acid content. Some Au clinical features
appear to be correlated with these findings; in particular, hyperactivity score appears to be related with some parameters of
the lipidomic profile and membrane fluidity. Oxidative stress and erythrocyte membrane alterations may play a role in the
pathogenesis of ASD and prompt the development of palliative therapeutic protocols. Moreover, the marked decrease in
NKA could be potentially utilized as a peripheral biomarker of ASD.
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Introduction
Autism spectrum disorders (ASD) are complex neuro-develop-
mental disorders characterized by impairment in social interaction
and communication, and exhibition of repetitive and stereotypic
behaviours. Diagnosis of ASD is based on clinical features only,
and at present there are no validated biomarkers for diagnostic
and/or screening purposes [1]. Genetic susceptibility, immuno-
logic alterations, and environmental factors have been proposed to
play an etio-pathogenic role in ASD [2]. It has been suggested that
oxidative stress may play a role in the etio-pathogenesis of ASD
[3–5]. Oxidative stress is defined as the disruption of the normal
intracellular balance between reactive oxygen species (ROS),
produced either during aerobic metabolism or as a consequence of
pathologic processes and antioxidant defence mechanisms [6].
Oxidative stress, in turn, induces the secretion of numerous
vasoactive and pro-inflammatory molecules [7] leading to
neuroinflammation [2]. Oxidative stress has been suggested to
underlie several other mental disorders, including schizophrenia
and bipolar disorder [8–10], and neurodegenerative pathologies
such as Alzheimer disease [11]. Oxidative stress is the result of
increased production of pro-oxidant species or decreased antiox-
idant defences; glutathione redox status has indeed been found to
be decreased in autistic patients, also in the post-mortem analysis
of Autistic brain tissues [12].
Oxidative stress can be detected by studying a panel of different
markers [13], some of which, such as DNA, proteins and
polyunsaturated fatty acid (PUFA) residues, are pathognomonic
of oxidative damage of biomolecules. It is worth mentioning that
lipid peroxidation was found to be elevated in autism [14] and that
PUFA are important for neurodevelopment [15]. Noteworthy, the
imbalance of membrane fatty acid composition and PUFA loss can
affect ion channels and receptors [16]. In particular, Ca2+ channel
deficiency was found in Au [17], but never correlated to
membrane parameters.
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The aim of our study was to evaluate an integrated biomarker
panel in Autistic (Au) children, in order to assess the possible
imbalance of their redox status. The rationale for the choice of the
parameters we examined was based on the strong correlation
between: a) erythrocyte fatty acid membrane profile and
preservation/degeneration of brain functions in aging and in
neurodegenerative diseases [18,19]; b) erythrocyte membrane v6/
v3 balance and inflammation markers [20]; c) peripheral and
central nervous system markers of oxidative stress [21]. All these
biomarkers are components of an intertwined biological system,
wherein erythrocyte membrane functional and structural charac-
teristics act as a sensor of pathological changes. The recognition of
biochemical alterations occurring in ASD subjects may also result
in therapeutic methods aimed at reducing some of the symptoms.
Also, the examined parameters are a potentially useful biomarker
of ASD.
Materials and Methods
Ethics Statement
The present study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human patients were approved by Local Ethical
Committee (Azienda USL Bologna, CE 10020- n.30, 06/04/
2010 prot 45424/10-03). Written consent was obtained from all
parents and also from children through pictures and simplified
information.
Subjects
A total of 48 children were approached as part of the present
case–control study. Of these, 25 had a diagnosis of Autism (Au)
and 23 were classified as Typically Developing (TD) children. Of
these, 21 were recruited for inclusion in the study from the autism
group (4 F and 17 M), and 20 in the TD group (6 F and 14 M).
Reasons for rejection included: taking fish oil supplements (two
subjects in the Au group), taking vitamins and/or other substance
known to have antioxidant properties (two subjects in Au group
and 3 subjects in TD group).
Au group mean age was 6.8 years (SD=2.23 years, median= 6
years, range 5–12 years); in TD group mean age was 7.6 years
(SD=1.96 years, median= 7 years, range 5–12 years). Both the
non-parametric comparison of the average age in the two groups
and the comparison by gender (chi-square test), were not
significant, confirming the comparability between cases and
controls.
All the patients were admitted to Child Neuropsychiatric Unit
of the Maggiore Hospital of Bologna (Neurological Sciences
Institute IRCCS-Bologna), for assessment by a comprehensive
diagnostic- neurological workup and regular follow-ups. None of
the autistic patients had active epilepsy at the time of blood and
urine sampling. One patient experienced a first and (at the
moment of writing this paper) single benign rolandic seizure six
months after the blood and urine collection (this patient was the
only one with a normal intellectual level). Any medical and
neurological comorbidity was excluded by electroencephalography
(recorded during awake and sleep), cerebral magnetic resonance
imaging, standard clinical and neurological examination, neuro-
metabolic and genetic investigations (including 550 band karyo-
type, and molecular assay for Fragile X and MECP2). No infective
or inflammatory disease was detected at the time of blood
collection. No subject underwent any surgery intervention in the
four months prior to blood and urine collection.
Autism diagnosis was made according to the Diagnostic and
Statistical Manual of Mental Disorders IV (DSM IV TR [22])
criteria, Autism Diagnostic Observation Schedule (ADOS) [23]
and Childhood Autism Rating Scale (CARS) [24] by two clinicians
(a child neuro-psychiatrist and a child psychologist) experienced in
the field of autism (P.V., F.R.). Developmental and cognitive levels
were assessed by Psychoeducational Profile-3 (PEP-3) [25] and
Leiter International Performance Scale–Revised (Leiter-R) [26].
Parents were questioned regarding the age of onset of early autistic
signs. Demographic and clinical features of Au group are
summarized in Table 1. Control group children were healthy
TD children, recruited in the local community, with no sign of
cognitive, learning and psychiatric involvement, as clinically and
anamnestically determined by three experienced clinicians (A.G.,
P.V., F.R.). All TD were attending mainstream school and had not
been subjected to stressful events. Dietary habits were assessed by a
Food Questionnaire. All patients and controls were on a typical
Mediterranean diet.
Biochemical Evaluations
Blood samples, obtained from Au and TD children, were
collected in Na2-EDTA (,9 mL) and heparin (,5 mL) vacutai-
ners. Some hematological parameters were carried out by routine
laboratory techniques. One ml Na2-EDTA whole blood was set
apart for lipidomics evaluation. The remaining blood was
centrifuged (10 min. at 10006g) in order to separate the plasma,
which was frozen at 280uC in 1 mL eppendorf sterile tubes. Na2-
EDTA and heparinised plasma was used for a radical absorbance
capacity (ORAC) test and protein carbonyl evaluation, respec-
tively. After diluting (1:1) the cell suspension with sterile Phosphate
Buffered Saline (PBS), mononuclear white blood cells were
separated from red cells by Ficoll (Histopaque 1077, Sigma,
St.Louis, MO, USA) density gradient centrifugation. Cells were
lysed in 1 mL TrizolH Reagent (Invitrogen, Milan, Italy) and
stored at 280uC for other evaluations. In order to remove all
Ficoll residue red blood cells were washed three times with PBS.
Erythrocytes in Na2-EDTA were stored at 4uC and then used for
the evaluation of Na+/K+-ATPase activity (NKA) and cell
membrane fluidity. Heparinised red blood cells (RBC) were used
for the evaluation of superoxide dismutase (SOD) and catalase
activity. In particular, for SOD activity measurement, heparinised
RBC were lysed in 4 volumes of ice-cold water and then stored at
280uC. The remaining heparinised RBC were diluted 30-fold in
PBS and subsequently lysed in 10 mM potassium phosphate buffer
pH 7.2. Lysates were stored at280uC and subsequently were used
for catalase activity evaluation. Spot urine samples (10 mL) from
Au and TD were collected. Proteinuria and creatinine determi-
nations were carried out by laboratory techniques. The remaining
urine was centrifuged at 1200 g for 10 min in order to remove
insoluble materials. Five mL of clear urine were aliquoted and
stored at 280uC for hexanoyl-lysine adduct (HEL) and 8-
isoprostane evaluations. The remaining urine was filtered with
0,45 mm filter, supplemented with 0.05% sodium azide and stored
at 280uC for 8-hydroxy-29-deoxyguanosine (8-oxo-dG) analysis.
Urinary 8-isoprostane. Urinary 8-isoprostane (also known
as 8-epi-PGF2a, 8-iso-PGF2a or 15-isoprostane F2t) was deter-
mined by the use of a competitive ELISA kit (Oxford Biomedical
Research Inc., Oxford, MI, USA). As suggested by the manufac-
turer, urine samples are diluted 1:5 with a buffer provided in the
kit. The 15- isoprostane F2t in the samples competes with 15-
isoprostane F2t conjugated to horseradish peroxidase (HRP) for
binding to a polyclonal antibody specific for 15-isoprostane F2t
coated on the microplate. A substrate was added and the
absorbance was measured at 450 nm in a microplate reader.
The 15-isoprostane F2t concentration was expressed in ng per
milligram of creatinine.
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Urinary hexanoyl-lysine adduct. Hexanoyl-lysine adduct
(HEL) concentration was measured by a competitive ELISA kit
(JaICA, Fukuroi, Shizuoka, Japan) in unfiltered urine of autistic
and control children. According to the manufacturer’s instruc-
tions, urine samples were diluted five times with PBS. Some urine
samples containing proteins were treated with 14 mg/mL alpha-
chymotrypsin in PBS (pH 7.4) and incubated at 37uC O.N.
Samples were filtered using ultra filters with cut-off molecular
weight 10 kDa (Amicon Ultra, Millipore, Cork, Ireland). The
absorbance was measured at 450 nm using a microplate reader.
The HEL concentration was expressed in nmol per milligram of
creatinine (nmol/mg creatinine).
Urinary 8-oxo-dG. Urinary 8-hydroxy-29-deoxyguanosine
(8-oxo-dG) was measured using the HT 8-oxo-dG ELISA Kit
(Trevigen Inc. Gaithersburg, MD, USA) according to the
manufacturer’s instructions. Briefly, filtered urine was diluted
1:20 with a buffer provided by the kit and added to a plate pre-
bounded with 8-oxo-dG. Bound and sample 8-oxo-dG compete
for binding to the anti-8-oxo-dG which was then added to the
plate; the antibody fraction captured by the immobilized 8-oxo-dG
in the plate was then detected by means of a HRP-conjugated
secondary antibody. The assay was developed with tetramethyl-
benzidine substrate (TMB) and the absorbance was measured in a
microplate reader at 450 nm. The 8-oxo-dG concentration was
expressed in ng per milligram of creatinine.
Protein carbonyl determination. Protein carbonyls were
determined in plasma samples using the Protein Carbonyl ELISA
kit (Enzo Life Sciences Inc. Farmingdale, NY, USA) following the
manufacturer’s instructions. Plasma (5 mL) was derivatized with
dinitrophenylhyidrazine (DNPH); derivatized proteins were then
adsorbed to an ELISA plate. The adsorbed protein was then
probed with biotinylated anti-DNP antibody followed by strepta-
vidin-linked horseradish peroxidase. The absorbance was read at
450 nm using a spectrophotometer plate reader (Victor II, Pelkin-
Elmer, Waltham, MA, USA). Plasma samples were assayed in
duplicate, and protein carbonyl concentration was expressed as
nanomoles of carbonyl groups per milligram of protein in the
sample (nmol/mg).
Plasma radical absorbance capacity (ORAC). The
ORAC assay was carried out on a Fluoroskan FLH ascent
(Thermo Fisher Scientific, Inc. Waltham, MA, USA) with
fluorescent filters (excitation wavelength: 485 nm; emission filter:
538 nm). following a previously published procedure [27].
Briefly, in the final assay mixture (0.2 mL total volume),
fluorescein sodium salt (85 nM) was used as a target of free radical
attack with 2,29-azobis(2-amidino-propane) dihydrochloride
(AAPH) as a peroxyl radical generator. Trolox, a water-soluble
analogue of vitamin E, was used as a standard control and
calibration curves were determined for 10, 20, 30, 40, 50 mM
solution. Fluorescence measurements, carried out at 37uC, were
recorded at 5 min intervals, up to 30 min after the addition of
AAPH. The ORAC values, calculated as difference of the areas
under the quenching curves of fluoresceine between the blank and
the sample, were expressed as Trolox equivalents (TE), pH=7.4.
All the assays were performed with three replicates.
Superoxide dismutase (SOD) activity. SOD activity was
determined in erythrocyte lysates by a competitive colorimetric
inhibition assay, as previously described [28,29]. This method is
based on water-soluble tetrazolium salt, WST-1 (2-(4-Iodophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monoso-
dium salt) (Dojindo Laboratories Co., Kumamoto, Japan), which
produces a water-soluble formazan dye upon reduction with the
superoxide anion generated by xanthine and xanthine oxidase
(Sigma-Aldrich, St. Louis, MO, USA). SOD activity reduces the
superoxide concentration and inhibits formazan formation. A
SOD standard curve was obtained; different dilutions of erythro-
cyte lysates were assayed in order to find a sample dilution that
falls within the range of standard curve linearity. Samples or
standards (10 mL) were incubated for 20 min at 37uC with 100 mL
reaction mixture containing 500 mMWST-1 and 75 mM xanthine
in 50 mM CHES (2-N-(Cyclohexylamino) ethanesulphonic acid,
pH 8.0. Finally, 10 mL Xanthine Oxidase (350 mU/mL) (Sigma-
Aldrich, St. Louis, MO, USA) was added. Formazan formation
was measured at 450 nm using a 96-well plate reader (Victor2
Multilabel Counter, Perkin-Elmer, Waltham, MA, USA). SOD
concentration, expressed in units per milligram of hemoglobin,
was determined using the SOD standard curve.
Catalase activity. Catalase activity was determined in
erythrocyte lysates using a method described by Ou and Wolff
[30], based on the specific reaction of FOX-1 reagent (250 mM
ammonium ferrous sulfate, 100 mM xylenol orange, 0,1 M
sorbitol, 25 mM H2SO4) with H2O2 to yield a color complex
having absorption maximum at 560 nm. The catalase causes
decomposition of H2O2 such that residual H2O2 is inversely
proportional to the activity of the catalase. One milliliter of
erythrocyte lysates was incubated for 4 min. with 100 mL of
2.2 mM H2O2. Subsequently, 50 mL aliquots of the incubation
mixtures were removed and rapidly mixed with 950 mL of FOX-1
reagent in eppendorf tubes, which were then incubated at room
temperature for 30 min. Absorbance was measured at 560 nm.
Catalase concentration was expressed in units per milligram of
hemoglobin.
Erythrocyte plasma membrane fluidity. Erythrocytes
plasma membrane fluidity was studied by determining the
fluorescence anisotropy (reciprocal of fluidity) of two probes,
TMA-DPH (1-(4-trimethylammoniophenyl)-6-phenyl-1,3,5-hexa-
triene), and DPH (1-6-phenyl-1,3,5-hexatriene); used to evaluate
membrane fluidity of the outer and the inner leaflet of cell
membrane, respectively [31]. The fluorescent probes were
purchased from Molecular Probes Inc (Eugene, OR, USA). The
incubation with TMA-DPH and DPH was performed as described
by Sheridan and Block [32]. Briefly, 3 ml of TMA-DPH and DPH
(1023 mol/L) were incubated for 5 min and 45 min respectively,
at room temperature (23uC) with 2 ml of erythrocyte membranes
(final concentration of 100 mg/mL) in 50 mmol/L Tris-HCl
buffer solution, pH 7.4. Fluorescence intensities (100 readings
each) of the vertical and horizontal components of the emitted
light were measured on a Perkin-Elmer MPF-66 spectrofluorom-
eter equipped with two glass prism polarizers (excitation wave-
length 365 nm, emission wavelength 430 nm). Sample tempera-
ture was maintained at 37uC using an external bath circulator
(Haake F3). Steady-state fluorescence anisotropy (r) of TMA-DPH
and DPH was calculated using the equation.
r~ IvG-Ihð Þ= Ivz2Ihð Þ
where G is an instrument factor correcting for unequal detection
of vertically (Iv) and horizontally (Ih) polarized light.
Na+/K+-ATPase activity. Na+/K+-activated Mg2+-depen-
dent ATPase activity was determined in cell membranes by the
Kitao method [33]. ATPase activity was assayed by incubating
1 mL of erythrocyte plasma membrane after sonication (three
bursts, 15 s each) at 37uC in a reaction medium containing MgCl2
(5 mmol/L), NaCl (140 mmol/L), KCl (14 mmol/L) in 40 mmol/
L Tris-HCl, pH 7.7. The ATPase reaction was initiated with the
addition of 3 mmol/L Na2ATP and stopped 20 min later by the
addition of 1 mL of 15% trichloracetic acid. The tubes were then
centrifuged at 1100 g for 10 min and the inorganic phosphate (Pi)
Oxidative Stress & Membrane Alterations in Autism
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hydrolysed from the reaction was measured in the supernatant by
a colourimetric assay using a KH2PO4 standard [34]. ATPase
activity, assayed in the presence of 10 mmol/L ouabain, was
subtracted from the total Mg2+-dependent ATPase activity to
calculate the activity of Na+/K+-ATPase. Protein concentration
was determined as described by Bradford [35], using serum
albumin as a standard. The interassay variation was 5.3%, while
the intra-assay variation was 8.1%.
Lipoperoxide levels (TBARs)
measurement. Lipoperoxide levels were evaluated using Cay-
man’s thiobarbituric acid reactive substances (TBARs) assay kit.
The product of fatty acid peroxidation, malondialdehyde (MDA),
reacts with thiobarbituric acid (TBA) to yield a product that is
measured fluorometrically. Membranes (100 mg of membrane
proteins) were centrifuged at 3000 g for 15 min after the addition
of 30% trichloroacetic acid, and 0.5 mL of the resulting
supernatant was mixed with 1.1 mL of TBA reagent (equal
volumes of 0.67% TBA aqueous solution and glacial acetic acid;
v/v). The reaction mixture was heated for 60 min at 95uC in a
sand bath. After cooling to room temperature, 5 mL of n-butanol
was added and the mixture was shaken vigorously for 2 min.
Thereafter, samples were centrifuged at 4000 g for 15 min, then
150 mL from each vial were loaded to the plate for fluorometric
assay and the fluorescence of samples and standards was read at an
excitation wavelength of 530 nm and an emission wavelength of
550 nm. The lipid peroxide level (Lp) was expressed in terms of
MDA content (mM), using 1,19,3,39-tetramethoxypropane as a
standard.
Sialic acid. Sialic acid content of RBC membranes was
determined by the periodate thiobarbituric acid method of Denny
et al. [36]. Briefly, membranes (1 mg membrane proteins/mL)
were first hydrolyzed in 0.05-mol/L H2SO4 in a final volume of
0.1 mL for 1 hour at 80uC to release SA [37]. Standards and
samples were both incubated with (assay samples) or without
(correction samples) 0.25 mL periodate solution (0.025 mol/L
periodic acid in 0.25 mol/L HCI) at 37uC for 30 minutes [38].
After reduction of excess periodate with 0.25 mL 0.32 mol/L
sodium thiosulfate, the reaction was completed by addition of
1.25 mL 0.1-mol/L thiobarbituric acid. The samples were heated
at 100uC for 15 minutes and then cooled to room temperature.
The product was extracted with acidic butanol and colorimetri-
cally assayed with a spectrophotometer at 549 nm. The readings
of correction samples were subtracted from those of assay samples,
thus corrected readings were obtained.
Protein content was determined by Bradford method to
normalize the sialic acid content using BSA as standard [35].
Erythrocyte membrane lipidomic analysis. The erythro-
cyte fatty acid membrane profile analysis was carried out as
previously described, using the erythrocyte membrane pellet
obtained by standard methods [39]. For this study, selection of
the erythrocyte fraction was made by modification of a literature
procedure for the selection of aged erythrocytes (red blood cell age
.3 months), with cells selected for high density and small diameter
compared to the average erythrocyte population [40].
One mL of whole blood was first centrifuged at 2000 g for
5 min to eliminate the plasma, and a second round of
centrifugation was then carried out at 4000 g at 4uC for 5 min
in order to yield a stratification by cell density. The bottom layer
(2.5 mm from the bottom of tube) consisted of erythrocyte cells,
which were evaluated for their diameter using a ScepterTM
2.0 Cell Counter (Merck Millipore, Milan, Italy) to characterize
the cell selection from each blood sample. The results were also
compared with the cell population obtained from standard density
gradient separation [41,42].
Briefly, lipids were extracted from erythrocyte membranes
according to the method of Bligh and Dyer [43]. The phospholipid
fraction was controlled by TLC as previously described [39], then
treated with KOH/MeOH solution (0.5 M) for 10 min at room
temperature and under stirring [44].
Fatty acid methyl esters (FAME) were extracted using n-hexane;
the hexane phase was collected and dried with anhydrous
Na2SO4. After filtration, the solvent was eliminated by evapora-
tion using a rotating evaporator, and the thin white film of the
FAME was subsequently dissolved in a small volume of n-hexane.
Approximately 1 mL of this solution was injected into the GC. A
Varian CP-3800 gas chromatograph, with a flame ionization
detector and an Rtx-2330 column (90% biscyanopropyl-10%
phenylcyanopropyl polysiloxane capillary column; 60 m, 0.25 mm
i.d., 0.20 mm film thickness) was used for the analysis. Temper-
ature was held at 165uC held for the initial 3 min, followed by an
increase of 1uC/min up to 195uC, held for 40 min, followed by a
second increase of 10uC/min up to 250uC, held for 5 min. The
carrier gas was helium, held at a constant pressure of 29 psi.
Methyl esters were identified by comparison with the retention
times of commercially available standards or trans fatty acid
references, obtained as described elsewhere [45].
Statistics
All experiments were carried out in duplicate or triplicate and
were usually repeated three times.
To compare Au and TD groups, normality tests were applied to
all numeric variables, following which appropriate parametric tests
(ANOVA, Student’s t for independent data) or the nonparametric
equivalent (Wilcoxon-Mann-Whitney) were used. Non-parametric
correlation (Spearman’s rho) was used to correlate clinical features
and biochemical data in the Au group (non-parametric ANOVA
for cognitive/developmental level). Differences were considered
significant at p,0.05.
To account for multiple testing we used the Benjamini and
Hochberg false discovery rate (FDR) [46]. FDR corrected p-values
(pFDR) were evaluated separately for a) comparisons of biochem-
ical parameters in Au and TD and b) correlations of clinical
features and biochemical data in Au. In particular, the compar-
isons of biochemical parameters included a1) erythrocyte mem-
brane features and molecules, oxidative stress markers (in urine
and plasma) and antioxidant enzyme activities in erythrocytes (12
comparisons); a2) erythrocyte membrane fatty acids (19 compar-
isons). As for the correlations between Au clinical features and
biochemical data, pFDR was calculated for CARS global score (31
comparisons), CARS activity level (hyperactivity) item (31
comparisons), CARS body use (stereotypes) item (31 comparisons),
cognitive/developmental impairment levels (31 comparisons). Age
was compared with all biochemical data (31 comparisons).
Even though it is usual to set at ,0.05 the significance level of
statistic tests, Benjamini & Hochberg [46], as well as others [47],
have argued that a more liberal threshold (as high as 0.1 or even a
bit higher) may be reasonable for pFDR.
Statistical analysis was performed using SAS v. 9.2.
Results
1. Comparisons between Au and TD
1.1 Oxidative stress markers in urine and plasma and
antioxidant enzymes activities in erythrocytes (Fig. 1 and
table 2). Peroxidation of arachidonic acid causes membranes to
release 8-isoprostane, a prostaglandin-F2-like compound. Oxi-
dized arachidonic acid or other omega-6 fatty acids, such as
linoleic acid, may also react with protein lysine residues, yielding
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HEL. Both 8-isoprostane (p,0.01; pFDR= 0.0278) and HEL
(p,0.05; pFDR= 0.076) were found in higher amount in the urine
of Au than in the urine of TD children (+47% and +45%,
respectively). However, the amount of 8-oxo-dG, derived from the
oxidation of nucleic acid bases by free radicals, did not
significantly differ between the two groups.
Plasma levels of carbonyl groups (an oxidative modification of
proteins) and plasma radical absorbance capacity (a measure of the
antioxidant capacity, which is reduced by free radicals) did not
differ between the two groups.
Similarly, neither SOD nor catalase enzymatic activity
measured in erythrocytes were found to differ between the two
groups.
1.2 Erythrocyte membrane features and molecules (Fig. 2
and table 2). TMA-DPH and DPH are two probes used to
evaluate membrane fluidity of the outer and the inner leaflet of cell
membrane, respectively. Taking into account that TMA-DPH and
DPH fluorescence anisotropy is inversely related to the fluidity of
the microenvironment where the probe is located, it was found
that membrane fluidity was decreased in Au with respect to TD.
The decrease reached the statistical significance (p,0.05) for both
the outer and inner membrane (pFDR= 0.0368, pFDR= 0.0469,
respectively).
The activity of Na+/K+-ATPase, an active ion transporter
localized in the plasma membrane, was markedly decreased
(266%) in Au in comparison with TD (p,0.0001; pFDR,0.0001),
Figure 1. Scatter plot showing oxidative stress markers in urine and plasma and antioxidant enzymes activities in erythrocytes.
Au=Autistic children; TD= typically developing children. Horizontal bars indicate means. Standard deviation values and whether parametric or not
parametric statistic tests were applied, are reported in Tab. 2. p,0.01 highly significant; p,0.05 significant; ns, not significant.
doi:10.1371/journal.pone.0066418.g001
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with no overlapping values between Au and TD (Au min. 1.41,
max. 3.38; TD min. 5.27, max. 10.75).
TBARS assay measures MDA generated from the decomposi-
tion of primary and secondary lipid peroxidation products.
TBARS were found to be significantly higher (+41%) in the
erythrocyte membrane from Au children in comparison with those
from TD children (p,0.01; pFDR=0.0125).
Sialic acid levels in erythrocyte did not differ between Au and
TD.
1.3 Analysis of erythrocyte membrane fatty acids
(Table 3). The percentage of oleic, palmitoleic and vaccenic
acids and, in general, total MUFA were increased in Au with
respect to TD children. This caused also a decrease in SFA/
MUFA ratio in Au with respect to TD children (p,0.05;
pFDR=0.07329).
The relative amount of the different PUFA was also altered,
since EPA and DHA-v3 acids were decreased in Au children
(216%, p,0.05, pFDR=0.10308 and 214%, p,0.01,
pFDR=0.0722, respectively), causing an increase in v6/v3 ratio
(+16%, p,0.05, pFDR=0.07329). The results were interpreted
using the fatty acid-based functional lipidomic approach [48].
2. Correlation between Au Clinical Features and
Biochemical Data (Main Results Reported in Fig. 3 and
Table 4)
Non-parametric correlation (Spearman’s rho) was used to
correlate clinical features and biochemical data in the Au group.
CARS global scores were inversely related with v6 arachidonic
acid (p,0.05; pFDR= 0.31104) and PUFA (p,0.05;
pFDR=0.18450). CARS activity level item scores (hyperactivity)
were negatively correlated with TMA-DPH (p,0.01;
pFDR=0.03720), oleic acid (p,0.05; pFDR=0.15035), v6
arachidonic acid (p,0.05; pFDR=0.15035), MUFA (p,0.05;
pFDR=0.11728) and PUFA (p,0.01; pFDR=0.03720), and
directly correlated with SFA (p,0.001; pFDR=0.00930), palmitic
acid (p,0.01; pFDR=0.03720), SFA/MUFA (p,0.001
pFDR=0.03720). TMA-DPH was correlated with age (p,0.01
pFDR=0.2376). CARS body use item scores (stereotypes) were not
significantly related to any biochemical marker.
When only cognitive/developmental impaired Au children (n:
19) were considered, the non parametric ANOVA revealed that
the level of cognitive/developmental impairment was inversely
related with v6 arachidonic acid (p,0.05; pFDR=0.33199), and
directly related with 8-isoprostane (p,0.05; pFDR=0.33199), total
SFA (p,0.05; pFDR=0.33199) and palmitic acid (p,0.05;
pFDR=0.33199), while cognitive impairment and total PUFA
showed only a trend of inverse correlation (p= 0.0553;
pFDR=0.33199).
Even if it was beyond the scope of this research, additional
correlations were performed within Au clinical features. We found
a significant correlation between CARS global score and other
clinical features, such as cognitive/developmental delay
(r = 0.52009, p,0.05; pFDR= 0.18450), hyperactivity
(r = 0.61669, p,0.01; pFDR= 0.10440), CARS body use item
scores (stereotypes) (r = 0.52009, p,0.01; pFDR= 0.18450). More-
over, the variable stereotypes was related to CARS activity levels
item score (hyperactivity) (r = 0,60308, p,0.01; pFDR= 0.03060).
3. Statistics
FDR analysis confirmed the statistical significance of most
uncorrected p values in both comparisons Au vs TD and in
correlations between clinical features and biochemical parameters.
Discussion
There is increasing evidence that autistic patients show excessive
ROS production and several studies reported the presence of
Table 2. Erythrocyte membrane features and molecules, oxidative stress markers in urine and plasma, antioxidant enzymes
activities in erythrocytes.
Mean values 6 St. Dev % difference Au vsTD Statistical significance
Au (N=21) TD (N=20) p values pFDR
Erythrocyte membrane features and molecules
Na+/K+-ATPaseu 2.5460.58 7.3961.62 266% ,0.0001 ,0.0001
TMA-DPHu 0.2760.02 0.2560.03 +8% 0.0123 0.0368
DPHu 0.2760.02 0.2560.03 +8% 0.0196 0.0469
TBARSu 0.7260.38 0.5160.37 +41% 0.0021 0.0125
Sialic Acidu 6.1964.36 7.6367.08 219% 0.7248 0.7248
Oxidative stress markers in urine
8-Isoprostaneu 3.0461.50 2.0760.54 +47% 0.0069 0.0278
HEL* 0.1660.09 0.1160.05 +45% 0.0380 0.0760
8-Oxo-dG* 484.806130.07 426.466163.64 +14% 0.2127 0.346
Oxidative stress markers in plasma
Carbonyl Groups* 0.3060.08 0.2760.11 +11% 0.2509 0.3763
ORACu 2.4760.86 2.3660.94 +5% 0.4573 0.5487
Antioxidant enzymes activities in erythrocytes
SOD activityu (Au N=12) 26.1064.02 25.4963.78 +2% 0.2960 0.3947
Catalase activity* (Au N= 12) 29.2866.34 31.25611.06 26% 0.5783 0.6309
Au: Autistic children; TD: typically developing children; p values were calculated with non parametric Wilcoxon-Mann-Whitney test (u) or parametric ANOVA test (*);
p,0.05: significant; p,0.01 highly significant; pFDR: Benjamini and Hochberg False Discovery Rate (FDR) corrected p-values.
doi:10.1371/journal.pone.0066418.t002
Oxidative Stress & Membrane Alterations in Autism
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e66418
different peripheral biomarkers of oxidative stress [13,49,50].
However, the great heterogeneity of the syndrome makes it
difficult to assess whether this finding is occasional and whether it
is restricted to a sub-group of patients. Moreover, not all oxidative
stress markers appear to be altered in patients, and it is still
unknown whether oxidative stress, if really present, is secondary to
a generic inflammatory status or due to genetic alterations still to
be recognized. In addition, most researchers addressing this
problem have a tendency to evaluate few markers at a time, thus
making it very difficult to compare data obtained in different
patient’s subgroups [51,52]. To our best knowledge, this is the first
study, which evaluated, at the same time, a wide range of different
but strongly related biological biomarkers in a group of Au
children that underwent a rigorous clinical characterization.
Figure 2. Scatter plot showing erythrocyte membrane features and molecules. Au=Autistic children; TD= typically developing children.
TMA-DPH and DPH values are inversely correlated with the outer and the inner membrane fluidity, respectively. TBARS= Thiobarbituric Acid Reactive
Substances. Horizontal bars indicate means. Standard deviation values and whether parametric or not parametric statistic tests were applied, are
reported in Tab. 2. p,0.01 highly significant; p,0.05 significant ns, not significant.
doi:10.1371/journal.pone.0066418.g002
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Among the oxidative stress parameters we evaluated, we found, in
Au compared to TD, a significant increase in TBARS, 8-
isoprostane and HEL, which are markers of lipid peroxidation.
No significant differences were found in the oxidative biomarkers
8-oxo-dG and ORAC. This finding suggests that the oxidative
stress-related phenomena are localized mainly at the cell surface.
Systemic involvement is suggested by detection of these markers
both in urine and in erythrocytes.
The fatty acid composition of the brain and neural tissues is
characterized by high PUFA concentrations, which play a very
important role in signal transduction [53], neuro-inflammation
[54] and cellular repair and survival [55]. Erythrocyte membrane
fatty acid composition is a very sensitive indicator of the status of
different tissues and may reflect the fatty acid composition of brain
[56]. In a number of neurodevelopmental conditions, including
Attention Deficit Hyperactivity Disorder (ADHD) and dyslexia,
reduced concentrations of erythrocyte membrane PUFA have
been reported [57]. Moreover, a polymorphism in the gene cluster
associated with the fatty acid desaturase-2 gene (FADS2) for Delta
6-desaturase (the rate-limiting step in PUFA synthesis) was
described in patients with ADHD [58,59], pointing to a possible
correlation between membrane fatty acid composition and
hyperactivity.
Table 5 summarizes published data about alterations in
erythrocyte membrane fatty acid composition in ASD children.
In our study, a significant increase of erythrocyte membrane
MUFA and of v6/v3 ratio (due to a decrease in EPA and DHA)
was shown. These results are partially superimposable to those
reported by Bell et al. [60]. Alteration in membrane lipid
composition was not related to dietary habits, since they did not
significantly differ between Au and TD, as evidenced by the Food
Questionnaire. On the other hand, oxidative stress is not a likely
explanation for the specific decrease of the v3, since this would
have also affected the v6 PUFA family. The observed imbalance
in v6/v3 ratio may lead to the proinflammatory status reported
previously in ASD children [12,61,62]. The significant increase in
MUFA may be representative of a feedback remodelling of
erythrocyte membrane lipid composition. It is interesting to note
that a study on adipocyte membranes showed DHA loss coexistent
with MUFA increase [63].
It has not escaped our notice that the membrane fluidity
decrease we observed cannot be directly explained on the ground
of these alterations in fatty acid composition. Schengrund et al.
[64] recently reported a decrease in cholesterol and a related
increase in GM1 ganglioside in erythrocyte membranes from ASD
children, which could affect membrane fluidity. However, we
failed to observe any change in membrane sialic acid - a
component of GM1 ganglioside, in Au patients.
Na+/K+-ATPase maintains intracellular gradients of ions that
are essential for cellular activities. Despite the crucial role of NKA
in cellular metabolism and the fact that it accounts for
approximately 30% of the total body energy consumption and
for 50% brain energy consumption, very little is known about
NKA in autism. In a mouse model of Angelman Syndrome, a
neurodevelopmental disorder associated with autism, an intrinsic
alteration of membrane properties of pyramidal neurons in
hippocampal area CA1 has recently been observed [65].
Alterations were also observed in resting membrane potential,
Table 3. Erythrocyte membrane Fatty Acid profile.
Mean values (6 St. Dev)
% differences
Au vs TD Statistical significance
Au (N=21) TD (N=20) p values pFDR
DHA omega 3 (22:6)* 4.8061.08 5.6260.67 214% 0.0065 0.07220
Total Monounsaturated Fatty Acids (MUFA)* 18.0361.25 17.0460.98 +6% 0.0076 0.07220
Vaccenic acid (18:1)u 1.3060.16 1.2060.11 +9% 0.0220 0.07329
Oleic acid (18:1)* 16.4261.25 15.6060.94 +5% 0.0228 0.07329
SFA/MUFAu 2.3860.24 2.5260.19 25% 0.0232 0.07329
Palmitoleic acid (16:1)u 0.360.08 0.2460.09 +25% 0.0262 0.07329
v6/v3 ratio* 6.6661.62 5.7660.67 +16% 0.0270 0.07329
EPA omega 3 (20:5)u 0.4360.16 0.5160.14 216% 0.0434 0.10308
Total Polyunsaturated Fatty Acids (PUFA)u 39.4061.80 40.1861.74 22% 0.1173 0.24763
Trans 18:1u 0.1160.05 0.1460.07 221% 0.1863 0.35397
Eicosatrienoic acid omega 6 (20:3)u 2.2560.45 2.1360.34 +6% 0.3714 0.64151
Stearic acid (18:0)* 18.5861.04 18.7860.88 21% 0.4940 0.76378
Total Saturated Fatty Acids (SFA)* 42.3161.96 42.6061.53 21% 0.6012 0.76738
Linoleic omega 6 (18:2)u 12.260.96 12.6661.34 24% 0.6012 0.76738
Total TRANSu 0.2360.08 0.2460.06 21% 0.6180 0.76738
Trans-ARAu 0.1260.06 0.1160.03 +9% 0.6756 0.76738
Arachidonic acid omega 6 (20:4)* 19.5761.67 19.3961.13 +1% 0.6866 0.76738
EFA deficiencyu 0.6660.07 0.6760.08 21% 0.7961 0.84033
Palmitic acid (16:0) * 23.7361.94 23.8261.48 0% 0.8810 0.88100
Au: Autistic children; TD: typically developing children; ARA, arachidonic acid; DHA, docosahexaenoic acid; EFA, essential fatty acids; EPA, eicosapentaenoic acid; MUFA,
monounsaturated fatty acids; PUFA; polyunsaturated fatty acids; SFA, saturated fatty acids; TRANS, transfatty acids; p values were calculated with non parametric
Wilcoxon-Mann-Whitney test (u) or parametric ANOVA test (*); p,0.05: significant; p,0.01 highly significant; pFDR: Benjamini and Hochberg False Discovery Rate
(FDR) corrected p-values.
doi:10.1371/journal.pone.0066418.t003
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Figure 3. Relevant correlations between Au clinical features and biochemical data. Au patients were divided into three levels of cognitive/
developmental impairment as follows: 1: mild, 2: moderate, 3: severe. TMA-DPH values are inversely correlated with the outer membrane fluidity.
SFA= Saturated Fatty Acids. CARS activity level item score denotes hyperactivity. p,0.01 highly significant; p,0.05 significant. More details are
reported in Tab.4.
doi:10.1371/journal.pone.0066418.g003
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Table 4. Significant correlations of clinical features and biochemical data in Autistic children.
CARS global scores CARS activity item (Hyperactivity)
Cognitive/developmental
impairment level Age
Total SFA NS r = 0.70834; p,0.001; pFDR = 0.00930 p,0.05; pFDR = 0.33199 NS
SFA/MUFA NS r = 0.57825; p,0.001;
pFDR=0.03720
NS NS
TMA-DPH NS r=20.58923; p,0.01; pFDR= 0.03720 NS r 20.6054; p,0.01;
pFDR= 0.2376
Total PUFA r =20.52589; p,0.05;
pFDR= 0.18450
r =20.58719; p,0.01; pFDR= 0.03720 p= 0.0553; pFDR= 0.33199 NS
Palmitic acid (16:0) NS r = 0.59763; p,0.01; pFDR = 0.03720 p,0.05; pFDR = 0.33199 NS
Arachidonic acid
v6 (20:4)
r =20.432: p,0.05;
pFDR= 0.31104
r =20.45377; p,0.05; pFDR= 0.15035 p,0.05; pFDR = 0.33199 NS
Total MUFA NS r =20.49446; p,0.05; pFDR= 0.11728 NS NS
Oleic acid (18:1) NS r =20.46048; p,0.05; pFDR= 0.15035 NS NS
8-isoprostane NS NS p,0.05; pFDR = 0.33199 NS
Non-parametric correlation (Spearman’s rho, r) was used to correlate clinical features (CARS, CARS activity item and Age) and biochemical data in the Autistic children
group. Non-parametric ANOVA was used for Cognitive/developmental impairment level. MUFA, monounsaturated fatty acids; PUFA; polyunsaturated fatty acids; SFA,
saturated fatty acids. p,0.05: significant; p,0.01 highly significant.
pFDR: Benjamini and Hochberg False Discovery Rate (FDR) corrected p-values.
doi:10.1371/journal.pone.0066418.t004
Table 5. Summary of published results on fatty acid composition of erythrocyte membrane.
fatty acid composition of
erythrocyte membrane Patients
Highly unsaturated fatty acids (HUFA) decreased One ASD patient [75]
Stearic acid (18:0) increased 18 Au children with developmental regression [76]
Arachidic acid (24:0) increased
Total SFA increased
Oleic acid (18:1 n-9) decreased
Nervonic acid (24:1) increased
Total MUFA decreased
Linoleic acid (18:2 n-6) increased
Arachidonic acid (ARA) (20:4 n-6) decreased
Docosapentaenoic acid (DPA) (22:5 n-6) increased
Docosapentaenoic acid (DPA) (22:5 n-3) decreased
Total v3 decreased
ARA:EPA ratio (20:4 n-6/20:5n-3) increased
Stearic acid (18:0) increased 11 children with classical autism or Asperger [76]
Arachidic acid (24:0) increased
Nervonic acid (24:1) increased
Docosapentaenoic acid (DPA) (22:5 n-6) increased
Docosapentaenoic acid (DPA) (22:5 n-3) decreased
Total v3 decreased
ARA:EPA ratio (20:4 n-6/20:5n-3) increased
Eicosenoic acid (20:1n9) increased 20 Au children with developmental regression (mean age 3.5 years) [77]
Erucic acid (22:1n9) increased
total MUFA increased
a-Linolenic acid (18:3 n-3) decreased 49 Au children (mean age 7.5 years) [78]
ARA:EPA ratio (20:4 n-6/20:5 n-3) increased
ARA, arachidonic acid; EPA, eicosapentaenoic acid; MUFA, monounsaturated fatty acids; PUFA; polyunsaturated fatty acids; SFA, saturated fatty acids.
doi:10.1371/journal.pone.0066418.t005
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threshold potential, and action potential amplitude correlated with
significant increases in the expression of the a1 subunit of Na+/
K+-ATPase [64]. In postmortem tissues from different brain
regions of autistic subjects, a specific increase in NKA in the
frontal cortex and cerebellum was found. The authors suggested
that such increase might be due to compensatory responses to
increased intracellular calcium concentration in autism [66].
On the contrary, we showed a very significant reduction of
erythrocyte NKA in Au compared to TD, in keeping with a similar
report by Kurup and Kurup [67]. There is no overlap between the
range values of the two groups, suggesting that this parameter
might be a biomarker of autism. Future work should be addressed
at understanding how sensitive and specific is the decrease of NKA
as far as autism is concerned. A number of other factors may affect
NKA; for example, a positive correlation between the molecular
activity of Na+/K+-ATPase units and the membrane content of
DHA has been shown [68] and a reduction of NKA has also been
related to oxidative stress [69,70]. Changes in ATPase activities
might stem from sub-conformational changes in the enzymes
depending on their microenvironment, indirectly reflecting
changes in surrounding lipids and in membrane fluidity [71].
Noteworthy, some clinical features were correlated with some
parameters of the lipidomic profile. In our study, hyperactivity is
the clinical aspect found to be most highly related to erythrocyte
membrane features. The higher the fluidity of the erythrocyte
membrane and the lower the PUFA concentration, the greater was
the hyperactivity level. Also, the severity of hyperactivity was
directly and highly correlated with erythrocyte SFA and palmitic
acid concentration. These data not only suggest that such
disequilibrium in membrane fatty acid composition may be a
useful tool to assess the severity of the autistic clinical picture, but
also suggest possible therapeutic interventions with a tailored and
balanced fatty acid intake. Two distinct double blind trials showed
an improvement in hyperactivity score in autistic children treated
with v3 supplementation [72,73]. Despite these encouraging
results, a recent Cochrane meta-analysis stated that ‘‘to date there
is no high quality evidence that omega-3 fatty acids supplemen-
tation is effective for improving core and associated symptoms of
ASD’’ [74]. Nevertheless, our data clearly show an imbalance of
membrane fatty acids and their correlation with relevant clinical
features, thus pointing to the importance of restoring the
membrane equilibrium. However, the intake of v3 should be
accompanied by antioxidant protection. For example, since our
data also show the alteration of the redox balance of Au,
supplementation of PUFA in the absence of antioxidant protection
might paradoxically worsen the picture, as, in oxidative milieu,
PUFA undergo a peroxidation process and may become, in turn,
pro-oxidant. Also, omega-6/omega-3 balance might modulate
neurotransmitters of the central nervous system: increased omega-
3 fatty acid concentrations in cell membranes have been shown to
affect serotonin and dopamine neurotransmission, especially in the
prefrontal cortex [75]. Taking into account that serotoninergic
and dopaminergic systems are deeply involved in ASD [76,77],
cell membrane lipid profile restoration could play a significant
therapeutic role in improving some ASD features.
Conclusions
Taken together, these results show significant erythrocyte
membrane alterations in Au, at structural and functional levels,
and an increase of lipid peroxidation markers. These alterations,
and in particular the marked decrease in NKA, may play a role in
the pathogenesis of ASD and potentially may be useful tools as
peripheral biomarkers of ASD to be exploited for a more precise
or an earlier diagnosis of ASD. Future work will be addressed at
understanding the reason(s) for the impairment of the NKA and
associated relevance to the pathogenesis of ASD. Finally, our data
suggest the presence of systemic alterations in ASD, and
emphasizes the possibility of an integrated approach aimed at
correcting the membrane defects by means of nutraceutic tools.
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